Suchergebnisse - "Kim, Seok Jin"

PubPharm (47)

1

Phase 3 SELENE study : ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

enthalten in: Blood advances | 2023

von Nastoupil, L. | Hess, G. | Pavlovsky, M. | +24

CommentIn: Blood Adv. 2023 Nov 28;7(22):7139-7140. - PMID 38015493

2

Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged ≥ 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP : A Prospective Cohort Study

enthalten in: Cancer research and treatment | 2022

von Jeong, S. | Kim, S. | Yoon, D. | +28

3

A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis : a prospective cohort study

enthalten in: Annals of hematology | 2020

von Yoon, S. | Eun, Y. | Huh, K. | +8

4

Asian variant of intravascular large B-cell lymphoma : a comparison of clinical features based on involvement of the central nervous system

enthalten in: The Korean journal of internal medicine | 2020

von Yoon, S. | Kim, W. | Kim, S.

5

Prognostic significance of interim PET/CT response for the treatment of advanced-stage marginal zone lymphoma in the post-rituximab era

enthalten in: Scientific reports | 2020

von Song, G. | Yoon, S. | Kim, S. | +12

6

A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003 : IVORY study): results of the final analysis

enthalten in: Annals of hematology | 2020

von Yoon, S. | Kim, S. | Yoon, D. | +10

7

Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma

enthalten in: Cytokine | 2020

von Yi, J. | Yoon, S. | Ryu, K. | +3

8

Clinical features and treatment outcomes of limited-stage mantle cell lymphoma : Consortium for Improving Survival of Lymphoma report

enthalten in: Annals of hematology | 2020

von Jo, J. | Kim, S. | Lee, H. | +14

9

Real world data on follicular lymphoma patients treated by rituximab-containing immunochemotherapy and rituximab maintenance

enthalten in: The Korean journal of internal medicine | 2020

von Kim, H. | Kang, W. | Sinn, D. | +3

10

The Glasgow Prognostic Score is a significant predictor of peripheral T-cell lymphoma (PTCL) treated with CHOP-based chemotherapy and comparable with PTCL prognostic scores

enthalten in: International journal of hematology | 2019

von Huh, S. | Oh, S. | Lee, S. | +10

1
2
3
4
5
Nächster »
[5]